Vor Biopharma Inc (NASDAQ:VOR) has a beta value of -0.51 and has seen 0.87 million shares traded in the recent trading session. The company, currently valued at $118.35M, closed the recent trade at $1.46 per share which meant it gained $0.14 on the day or 10.78% during that session. The VOR stock price is -115.07% off its 52-week high price of $3.14 and 56.85% above the 52-week low of $0.63. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.38 million shares traded. The 3-month trading volume is 688.41K shares.
The consensus among analysts is that Vor Biopharma Inc (VOR) is Buy stock at the moment, with a recommendation rating of 1.14. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Vor Biopharma Inc (NASDAQ:VOR) trade information
Sporting 10.78% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VOR stock price touched $1.46 or saw a fall of -0.69%. Year-to-date, Vor Biopharma Inc shares have moved 31.74%, while the 5-day performance has seen it change 15.14%. Over the past 30 days, the shares of Vor Biopharma Inc (NASDAQ:VOR) have changed 63.51%. Short interest in the company has seen 1.71 million shares shorted with days to cover at 2.99.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 75.67% from the levels at last check today. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the latest price level in today’s session is -310.96% off the targeted high while a plunge would see the stock gain -310.96% from the levels at last check today.
Vor Biopharma Inc (VOR) estimates and forecasts
Figures show that Vor Biopharma Inc shares have outperformed across the wider relevant industry. The company’s shares have gained 61.38% over the past 6 months, with this year growth rate of 18.86%, compared to 16.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -73.43% over the past 5 years.
VOR Dividends
Vor Biopharma Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Vor Biopharma Inc (NASDAQ:VOR)’s Major holders
Insiders own 1.17% of the company shares, while shares held by institutions stand at 81.25% with a share float percentage of 82.21%. Investors are also buoyed by the number of investors in a company, with Vor Biopharma Inc having a total of 92.0 institutions that hold shares in the company. The top two institutional holders are RA CAPITAL MANAGEMENT, L.P. with over 22.75 million shares worth more than $22.75 million. As of 2024-06-30, RA CAPITAL MANAGEMENT, L.P. held 33.439% of shares outstanding.
The other major institutional holder is FMR LLC, with the holding of over 7.08 million shares as of 2024-06-30. The firm’s total holdings are worth over $7.08 million and represent 10.4009% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund. As of Oct 31, 2024, the former fund manager holds about 2.09% shares in the company for having 1.44 shares of worth $2.1 million while later fund manager owns 1.39 shares of worth $2.02 million as of Sep 30, 2024, which makes it owner of about 2.02% of company’s outstanding stock.
